Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on pricing and tariffs.
Trending
- Elite 8 winners, losers: UConn comeback, droughts end, Duke chokes again
- Trump warns US could ‘take the oil in Iran’ as Mideast war escalates
- The Iran war; high gas prices; Trump’s approval ratings : NPR
- U.S. will let Russian oil tanker reach Cuba, breaking Trump’s effective fuel blockade
- ICE officers could remain at airports after TSA workers are paid : NPR
- Amid Michigan’s blissful trek to Final Four, Wolverines AD focuses on keeping Dusty May amid UNC chatter
- Costco to open its first stand-alone gas station in Mission Viejo
- TSA pay may be coming, but airport delays could persist and ICE agents may not leave soon
Monday, March 30
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
